New Phase 4 Study Shows Higher Rates Of Clinical And Microbiological Success For Zyvox Versus Vancom
22nd October 2010 -
Views: 1574
Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox(R) (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint.
Mudgee Inventor Launches Bearing Packer for Mechanics
26th September 2011 -
Views: 6311
Launch of a new invention to change the mechanics industry
Three-year Follow-up Data Confirm Safety And Survival Benefit In Chinese Liver Failure Patients Trea
14th October 2010 -
Views: 1457
Vital Therapies, Inc., (VTI) today announced that a poster is being presented at the American Association for the Study of Liver Diseases (AASLD) meeting in Boston on Tuesday, November 2nd.
Final Analysis Of Landmark Ipass Study Confirms That Iressa (gefitinib) Is A Valuable Option For The
12th October 2010 -
Views: 1538
The mature IPASS OS data confirm that patients with EGFR
mutation-positive advanced non-small cell lung cancer (NSCLC) had better
outcomes, regardless of which treatment arm they were in, compared to
patients with EGFR mutation-negative disease.
New Research: Stop The World I Want To Get Off!
11th October 2010 -
Views: 1503
Young Australians are shutting down Facebook, turning their phones to silent and losing themselves in literature to counterbalance their frenetic digital lives according to the latest report from Australia’s specialist youth media and communications company, Lifelounge Group, in conjunction with Sweeney Research.